Activity value 76india Supplier,Last transaction date:
2026-01-23
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for u pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 8 transactions, with a transaction quantity of 104 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025680.80
202681040
Bill of lading data
<
1/15
>
Trade date
2026/01/23
B/L No.
0400706
Suppliers
u pharma
Buyers
to the order of :
POLs
mumbai (ex bombay)
PODs
kuala lumpur
Supply area
India
Purchas area
Malaysia
Weight
——
Amount
——
Hs code
29339990
Product tags
bat,oct
Product description
BATCH NO S A 2881125 MFG DATE NOV 2025 EXP DATE OCT 2030
Expand
u pharma is india Supplier,
and primarily engages in the import and export business of products such as pharmaceutical,bat,raw material.
According to the 52wmb.com global trade database, as of 2026-01-23, the company has completed 74 international trades,
with its main trading regions covering malaysia,kyrgyzstan,poland etc.
The core products include HS29339990,HS29335990,HS35079069 etc,
and its main trading partners are wuhan xinru chemical industrial co,alfa laboratories inc.,.pannonpharma pharmaceutical ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on u pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.